Agilent Technologies (NYSE:A) Rating Increased to Strong-Buy at Sanford C. Bernstein

Agilent Technologies (NYSE:A) was upgraded by investment analysts at Sanford C. Bernstein to a “strong-buy” rating in a research report issued on Thursday,Zacks.com reports.

A has been the subject of a number of other research reports. HSBC dropped their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Wolfe Research reissued a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Morgan Stanley decreased their price objective on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. UBS Group dropped their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Finally, Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $160.88.

Agilent Technologies Trading Up 0.6%

A opened at $136.29 on Thursday. The business has a 50 day simple moving average of $122.86 and a two-hundred day simple moving average of $126.32. The firm has a market capitalization of $38.49 billion, a price-to-earnings ratio of 27.37, a PEG ratio of 2.41 and a beta of 1.26. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. Agilent Technologies has a one year low of $108.35 and a one year high of $160.27.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.08. The business had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business’s revenue was up 10.0% on a year-over-year basis. During the same quarter last year, the business posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts predict that Agilent Technologies will post 6 EPS for the current year.

Hedge Funds Weigh In On Agilent Technologies

A number of institutional investors have recently added to or reduced their stakes in A. Brighton Jones LLC lifted its position in Agilent Technologies by 6.1% during the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after buying an additional 270 shares during the period. Jones Financial Companies Lllp boosted its holdings in shares of Agilent Technologies by 15.9% during the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock valued at $602,000 after buying an additional 769 shares in the last quarter. Geneos Wealth Management Inc. grew its position in shares of Agilent Technologies by 54.8% in the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after buying an additional 212 shares during the period. Acadian Asset Management LLC grew its position in shares of Agilent Technologies by 16.5% in the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after buying an additional 758 shares during the period. Finally, Sivia Capital Partners LLC bought a new position in shares of Agilent Technologies in the 2nd quarter worth about $273,000.

More Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent completed its acquisition of Biocare Medical, strengthening its diagnostics and clinical pathology offerings and potentially improving long-term growth prospects. Agilent finalizes Biocare Medical takeover
• Positive Sentiment: Sanford C. Bernstein initiated coverage with an outperform rating and a $155 price target, which may bolster investor confidence in additional share price upside. Benzinga coverage
• Positive Sentiment: Recent commentary highlights Agilent’s post-earnings resilience, reflecting steady investor interest after the company beat expectations and raised/confirmed guidance. Why Is Agilent (A) Up 0.1% Since Last Earnings Report?
• Neutral Sentiment: Piper Sandler initiated coverage at Neutral with a $150 target, which is supportive but less bullish than Bernstein’s call. Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler
• Neutral Sentiment: Articles about dividend reliability and broader adoption of Agilent software suggest steady fundamentals, but they are less likely to drive a major near-term stock move. Is Agilent Technologies (NYSE:A) Still A Reliable Dividend Story? Shanghai ICRD Adopts Agilent Software
• Neutral Sentiment: Agilent’s stock has been trading with modest strength following the earnings release, but the move appears tied more to execution and sentiment than to any single dramatic catalyst. Agilent (A) stock trades up, here is why

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.